Shanghai RAAS Blood Products Co., Ltd. is a leading biotechnology company specializing in the production and distribution of blood plasma-derived products. Operating within the pharmaceutical sector, ... Shanghai RAAS Blood Products Co., Ltd. is a leading biotechnology company specializing in the production and distribution of blood plasma-derived products. Operating within the pharmaceutical sector, the company focuses on manufacturing human blood plasma proteins, which are critical in the treatment of immune deficiencies, hemophilia, and other blood-related disorders. With a firmly established role in the healthcare industry, Shanghai RAAS plays an integral part in the medical supply chain, particularly in regions where demand for safe and effective blood products is high. In addition to its therapeutic products, the company invests in research and development to enhance product efficacy and expand its portfolio. Shanghai RAAS utilizes advanced plasma collection and fractionation techniques to ensure the highest quality and safety standards. This commitment positions the company as a key player in China's growing pharmaceutical and biotechnology markets, emphasizing its importance in addressing public health challenges through innovative medical solutions.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Greenhouse Gas (GHG) Emissions data disclosed by Shanghai RAAS Blood Products

We reviewed Shanghai RAAS Blood Products's website and available disclosure materials for the 2023 reporting period and did not identify any reported Greenhouse Gas (GHG) Emissions data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Shanghai RAAS Blood Products's data?

Start your 30-day free trial to request a data review for Shanghai RAAS Blood Products.

Start Free Trial

Legal Center Contact Us